HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma
Authors
Keywords
-
Journal
LEUKEMIA
Volume 32, Issue 3, Pages 703-711
Publisher
Springer Nature
Online
2017-11-14
DOI
10.1038/leu.2017.299
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma
- (2016) Ichiro Fukumoto et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Activated Transcription Factor 3 in Association with Histone Deacetylase 6 Negatively Regulates MicroRNA 199a2 Transcription by Chromatin Remodeling and Reduces Endothelin-1 Expression
- (2016) Chen Li et al. MOLECULAR AND CELLULAR BIOLOGY
- Expression and function of microRNA-27b in hepatocellular carcinoma
- (2016) SHUJIE HE et al. Molecular Medicine Reports
- Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines
- (2016) Zong-yang Li et al. NEUROCHEMICAL RESEARCH
- MicroRNA-27b suppresses Helicobacter pylori-induced gastric tumorigenesis through negatively regulating Frizzled7
- (2016) YAN GENG et al. ONCOLOGY REPORTS
- MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma
- (2016) Xin-Fang Sun et al. TUMOR BIOLOGY
- Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death
- (2015) Yuko Mishima et al. BRITISH JOURNAL OF HAEMATOLOGY
- MicroRNA-27b suppresses tumor progression by regulating ARFGEF1 and focal adhesion signaling
- (2015) Rei Matsuyama et al. CANCER SCIENCE
- BATF2 Deficiency Promotes Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs
- (2015) Z. Liu et al. CLINICAL CANCER RESEARCH
- Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma
- (2015) J. E. Amengual et al. CLINICAL CANCER RESEARCH
- Drug-releasing mesenchymal cells strongly suppress B16 lung metastasis in a syngeneic murine model
- (2015) Augusto Pessina et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1
- (2015) Ryou-u Takahashi et al. Nature Communications
- Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients
- (2015) Emilia L Lim et al. GENOME BIOLOGY
- Histone deacetylase 6 activity is critical for the metastasis of Burkitt’s lymphoma cells
- (2014) Ning Ding et al. Cancer Cell International
- NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma
- (2014) Lina Odqvist et al. MODERN PATHOLOGY
- In Vitro and In Vivo Interactions between the HDAC6 Inhibitor Ricolinostat (ACY1215) and the Irreversible Proteasome Inhibitor Carfilzomib in Non-Hodgkin Lymphoma Cells
- (2014) G. Dasmahapatra et al. MOLECULAR CANCER THERAPEUTICS
- The effects of a histone deacetylase inhibitor on biological behavior of diffuse large B-cell lymphoma cell lines and insights into the underlying mechanisms
- (2013) Ying Cai et al. Cancer Cell International
- MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas
- (2013) Sang Y Ha et al. MODERN PATHOLOGY
- Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1β signaling in osteoarthritis fibroblast-like synoviocytes
- (2013) J.H. Wang et al. OSTEOARTHRITIS AND CARTILAGE
- Functional cooperation of miR-125a, miR-125b and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells
- (2013) S Wang et al. Cell Death & Disease
- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
- (2012) L. Santo et al. BLOOD
- The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
- (2012) B. M. Slomovitz et al. CLINICAL CANCER RESEARCH
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
- (2011) E. Campo et al. BLOOD
- Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors
- (2009) Annunziata Gloghini et al. BRITISH JOURNAL OF HAEMATOLOGY
- Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas
- (2009) Lena Marquard et al. HISTOPATHOLOGY
- Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase–2 and –7 and E-cadherin
- (2009) Yasuyoshi Miyata et al. HUMAN PATHOLOGY
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: Pathological significance in early- and late-onset breast carcinoma
- (2008) Satyabrata Sinha et al. Molecular Cancer
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
- (2008) Witold Filipowicz et al. NATURE REVIEWS GENETICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now